70 percent of all smokers would like to quit their habit...

It looks like other drug companies have worked out that the way forward with medication to help individuals give up smoking is not about nicotine replacement but about drugs that will help stop the cravings for cigarettes. Following on from the groundbreaking medication Champix made by the drug company Pfizer and also in view of the fact that Champix has been seen to be far more effective in helping people to give up smoking than nicotine replacement therapies other drug companies are experimenting with drugs to stop cravings.

The market for smoking cessation drugs is potentially huge but potential customers have to be made aware that the medication that they are given will really have a big effect and help them to give up smoking. Some research that we have studied at Ukmedix News shows that over 70 percent of all smokers would like to quit their habit but say that they just can't. The majority of smokers have attempted to give up their unhealthy habit in the past but have failed.

Researchers are aware that nicotine when it gets into the blood triggers a response from the brain to release a compound called dopamine that is induces a pleasurable sensation. So in a way it is not the nicotine that they are directly addicted to but more the pleasurable sensation that the nicotine eventually produces. Scientists who are aware of this therefore are concentrating on medications that will stop the pleasurable sensation from occurring when people smoke so that the habit will become completely worthless for them.

In fact this is how the smoking cessation drug Champix works as it reduces the enjoyment of cigarettes as well as the desire to keep on smoking. This doubled pronged attack on smoking is why the Champix drug is getting very high success rates.